+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acadia Pharmaceuticals Inc - logo

Acadia Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson's disease, Phase II trial for the treatment of schizophrenia and Phase II study for the treatment of Alzheimer's disease. The company was founded in 1993 and is headquartered in San Diego, California.

Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • September 2021
  • 325 Pages
  • Global
From
Treatment Resistant Depression - Pipeline Insight, 2024 - Product Thumbnail Image

Treatment Resistant Depression - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Central Nervous System Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Central Nervous System Collaboration and Licensing Deals 2019-2024

  • Report
  • April 2024
  • 700 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • May 2024
  • 898 Pages
  • Global
From
Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 269 Pages
  • Global
From
Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 110 Pages
  • Global
From
Global Neurodegenerative Drugs Market by Drug Class (Cholinesterase Inhibitors, Decarboxylase Inhibitors, Dopamine Agonist), Indication (Alzheimer's Disease, Dementia, Huntington's Disease), Sales Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Neurodegenerative Drugs Market by Drug Class (Cholinesterase Inhibitors, Decarboxylase Inhibitors, Dopamine Agonist), Indication (Alzheimer's Disease, Dementia, Huntington's Disease), Sales Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 195 Pages
  • Global
From
Global Parkinson's Disease Therapeutics Market by Type (Intestinal Infusion, Oral, Subcutaneous), Drug Class (Anticholinergic, Carbidopa/Levodopa, COMT Inhibitor), Distribution Channel, End Use - Forecast 2024-2030 - Product Thumbnail Image

Global Parkinson's Disease Therapeutics Market by Type (Intestinal Infusion, Oral, Subcutaneous), Drug Class (Anticholinergic, Carbidopa/Levodopa, COMT Inhibitor), Distribution Channel, End Use - Forecast 2024-2030

  • Report
  • March 2024
  • 186 Pages
  • Global
From
Global Central Nervous System Treatment Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Central Nervous System Treatment Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Fragile X Syndrome Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2030 - Product Thumbnail Image

Fragile X Syndrome Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2030

  • Drug Pipelines
  • February 2022
  • 60 Pages
  • Global
From
Schizophrenia - Pipeline Review, H2 2020 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 440 Pages
  • Global
From
Global Neurologic Disorders Therapeutics Market 2022-2026 - Product Thumbnail Image

Global Neurologic Disorders Therapeutics Market 2022-2026

  • Report
  • May 2022
  • 120 Pages
  • Global
From
Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • May 2018
  • 204 Pages
  • Global
From
Dementia (Central Nervous System) - Drugs In Development, 2021 - Product Thumbnail Image

Dementia (Central Nervous System) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 682 Pages
  • Global
From
Neurodegenerative Disorder Therapeutics Global Market Report 2024 - Product Thumbnail Image

Neurodegenerative Disorder Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Autism Spectrum Disorders Treatment Global Market Report 2024 - Product Thumbnail Image

Autism Spectrum Disorders Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Global Neurodegenerative Diseases Drugs Market Report and Forecast 2023-2028 - Product Thumbnail Image

Global Neurodegenerative Diseases Drugs Market Report and Forecast 2023-2028

  • Report
  • September 2023
  • 188 Pages
  • Global
From
Major Depressive Disorder (MDD) - Market Insights, Epidemiology and Market Forecast - 2028 - Product Thumbnail Image

Major Depressive Disorder (MDD) - Market Insights, Epidemiology and Market Forecast - 2028

  • Report
  • February 2020
  • 253 Pages
  • Global
From
Musculoskeletal Pain - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Musculoskeletal Pain - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Loading Indicator